The National Biotechnology Research Park (#NBRP)—Taiwan’s first #ecosystem for #biomedical research on a national level—showcases its unparalleled role in advancing R&D and industry-academic collaborations. This year, four cutting-edge resident companies shined at Healthcare+ Expo Taiwan 2024 with breakthroughs that transform biotech innovation into global solutions.

BPM Bio Preventive Medicine Corp. (6810.TWO)
Global reaches across five continents! By 2025, BPM will initiate a clinical trial with nearly 1,000 participants in Saudi Arabia to support insurance coverage and reach into the nation’s medical systems.

PharmaEssentia Corp (6446.TW)
Expanding from blood cancer treatments to autoimmune diseases. Exciting plans to file for a U.S. IND for PEG-IL-2 by the end of 2025!

AcadeMab Biomedical
Pioneering nucleic acid vaccines and cationic lipid technologies, leading Taiwan’s vaccine innovations!

Rock BioMedical
Revolutionizing drug development with glycoengineering, focusing on vaccines and antibody therapies.

Together, NBRP and these innovators are breaking barriers, driving global biotech progress, and redefining the future of healthcare.

Explore more: https://news.gbimonthly.com/tw/article/show.php?num=73176

???? #NBRP #BiotechInnovation #HealthcareExpo2024 #Globalbio